Cholesterol Solutions Today:The Good & The Bad

Researchers have discovered one potential mechanism by which briefly cutting off, then restoring, blood flow to arteries prior to a heart attack lessens the damage caused, according to a study published in the journal Cardiovascular Research. The new mechanism points to how future drugs could provide protection ahead of heart attacks and strokes for those at highest risk. In the nearer term, the work may help to prevent damage caused as U.S.

Having discovered how a lowly, single-celled fungus regulates its version of cholesterol, Johns Hopkins researchers are gaining new insight about the target and action of cholesterol-lowering drugs taken daily by millions of people to stave off heart attacks and strokes. Their work appears in the December issue of Cell Metabolism. In humans, statin drugs inhibit an enzyme, HMG-CoA reductase, to lower blood cholesterol.

Researchers have new evidence to show that the heart beats to its own drummer, according to a report in the December issue of the journal Cell Metabolism, a Cell Press publication. They've uncovered some of the molecular circuitry within the cardiovascular system itself that controls the daily rise and fall of blood pressure and heart rate. The findings might also explain why commonly used diabetes drugs come with cardiovascular benefits, according to the researchers.

After you eat a burger and fries or other fat-filled meal, a protein produced by the liver may send a signal that fat is on the way, suggests a report in the December issue of the journal Cell Metabolism, a Cell Press publication. Researchers have found in mice that the liver produces a protein called adropin, which rises in response to high-fat foods and falls after fasting.

Deep venous thrombosis (DVT), the formation of blood clots in the lower limbs, is the third-most common vascular disease in North America after heart attack and stroke, and is a frequent complication in hospitalized patients. DVT is a potentially serious condition that can lead to rapid death from pulmonary embolism if untreated, and has become such a serious health concern that the U.S.

The link between food marketing and the growing childhood obesity epidemic is the focus of a $6.4 million grant from the Robert Wood Johnson Foundation to the Rudd Center for Food Policy and Obesity at Yale University. Principal investigators, Rudd Center Director Kelly D.

Rutgers, The State University of New Jersey, has received a four-year, $10 million grant from the Robert Wood Johnson Foundation to establish the Institute for Food, Nutrition and Health, on its George H. Cook Campus. Rutgers President Richard L. McCormick announced his intention to establish the new institute during his Annual Address to the University Community on Sept. 19.

Biocompatibles International plc is pleased to announce that The International Neuroscience Institute (INI), Hannover today held a press conference which covered the following: - Milestone in Medical Treatment - First ever Treatment of Stroke Patient with Stem Cell Therapy Prod

New research has found that the availability of a portable eight-slice computed tomography (CT) scanner in an emergency room can significantly increase the number of stroke victims who receive a potentially life-saving treatment. Results of the study, conducted at North Shore Medical Center (NSMC)-Salem Hospital in Salem, Mass., will be presented at the annual meeting of the Radiological Society of North America (RSNA).

Once-promising drugs that were abandoned in the fight against breast cancer still could be effective in obese patients, new research suggests. In laboratory tests, hormones produced by fat cells stimulate breast cancer cells to migrate and invade surrounding tissues, scientists at Emory University School of Medicine found. A class of drugs called epithelial growth factor receptor (EGFR) inhibitors could block the stimulatory effects of the hormones.